Technology Transfer and Transition Services. NOVARTIS shall (a) transfer to LICENSEE the embodiments of the Licensed Technology set forth in Schedule B-2; and (b) perform the services set forth in Schedule B-2 (where the activities under subsections (a) and (b) shall be collectively referred to as “Transfer Activities”). NOVARTIS shall use commercially reasonable efforts to perform the Transfer Activities and complete such Transfer Activities within the time periods specified in Schedule B-2.
Appears in 3 contracts
Sources: License Agreement, License Agreement (Magenta Therapeutics, Inc.), License Agreement (Magenta Therapeutics, Inc.)